ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 6,611,000 Value ($000) $7,745 Avg Close — Range —
Q3 2023
Shares 4,254 Value ($000) $3,946 Avg Close — Range —